Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
Abroad (travel likely)RecruitingPHASE2
Conditions
Solid Tumor · Advanced Cancer · Metastatic Cancer · Gastric Cancer · Gastroesophageal Junction Carcinoma · Esophageal Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
I-Mab Site 1016, Goodyear, Arizona, United States
Contact: Study coordinator (I-Mab PI - 1016)I-MAB Site 1005, Duarte, California, United States
Contact: Study coordinator (I-MAB PI - 1005)I-Mab Site 1002, Boston, Massachusetts, United States
Contact: Study coordinator (I-Mab PI - 1002)I-Mab Site 2001, Beijing, China
Contact: Study coordinator (I-Mab PI - 2001)I-Mab Site - 4001, Kashiwa, Japan
Contact: Study coordinator (I-Mab PI 4001)I-Mab Site 4005, Tokyo, Japan
Contact: Study coordinator (I-Mab PI - 4005)